{"product_id":"elicuis-5mg-con-20-tabletas-apixaban","title":"Elicuis 5mg with 20 tablets (Apixaban)","description":"\u003ch2\u003eCategory\u003c\/h2\u003e\n\u003cp\u003eAnticoagulants\u003c\/p\u003e\n\n\u003ch2\u003eLine\u003c\/h2\u003e\n\u003cp\u003eOral Anticoagulants\u003c\/p\u003e\n\n\u003ch2\u003eBrand\u003c\/h2\u003e\n\u003cp\u003eElicuis\u003c\/p\u003e\n\n\u003ch2\u003eMolecule\u003c\/h2\u003e\n\u003cp\u003eApixaban\u003c\/p\u003e\n\n\u003ch2\u003ePresentation\u003c\/h2\u003e\n\u003cp\u003e20 tablets of 5 mg\u003c\/p\u003e\n\n\u003ch2\u003eLaboratory\u003c\/h2\u003e\n\u003cp\u003ePfizer\u003c\/p\u003e\n\n\u003ch2\u003eIndications\u003c\/h2\u003e\n\u003cp\u003eElicuis is indicated for the prevention of thromboembolic events in patients with non-valvular atrial fibrillation, as well as for the prevention and treatment of deep vein thrombosis and pulmonary embolism. This medication acts as a direct factor Xa inhibitor, which leads to a reduction in thrombin formation and, therefore, in clot formation. The administration of Elicuis must be carefully evaluated in specific clinical contexts, considering the patient's medical history and the presence of associated risk factors.\u003c\/p\u003e\n\n\u003ch2\u003eComposition\u003c\/h2\u003e\n\u003cp\u003eEach Elicuis tablet contains 5 mg of apixaban as the active ingredient, as well as excipients necessary for the formulation of the medication.\u003c\/p\u003e\n\n\u003ch2\u003eContraindications\u003c\/h2\u003e\n\u003cp\u003eThis medication is contraindicated in patients with known hypersensitivity to apixaban or to any of the excipients in the formulation. Likewise, its use is not recommended in patients with conditions that increase the risk of significant bleeding, such as active gastrointestinal bleeding, intracranial hemorrhages, or in those with severe liver diseases.\u003c\/p\u003e\n\n\u003ch2\u003ePrecautions\u003c\/h2\u003e\n\u003cp\u003eCaution should be exercised when using Elicuis in patients over 75 years of age, in those with moderate or severe renal insufficiency, as well as in those receiving other anticoagulant treatments. Regular monitoring of renal function and dose adjustment as needed is essential. Additionally, patients should be warned about the risk of bleeding, and it is recommended that they inform their doctor about any signs of unusual bleeding.\u003c\/p\u003e\n\n\u003ch2\u003eStorage\u003c\/h2\u003e\n\u003cp\u003eStore in a cool, dry place, at a temperature not exceeding 30°C. Keep out of reach of children.\u003c\/p\u003e\n\n\u003cp\u003ePrescription required.\u003c\/p\u003e\n\u003cp\u003eConsult your doctor.\u003c\/p\u003e","brand":"Pfizer","offers":[{"title":"Default Title","offer_id":45848237244641,"sku":"8027950210466","price":1102.24,"currency_code":"MXN","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0722\/1500\/3361\/files\/8027950210466_804f7bb0-8888-4fcb-8d3b-868d03257b79.png?v=1744672461","url":"https:\/\/wecarepharma.mx\/en\/products\/elicuis-5mg-con-20-tabletas-apixaban","provider":"WeCare Pharma","version":"1.0","type":"link"}